IN THE NEWS
Benzinga
Shares of Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) lost more than 58 percent of their value Monday after the company reported disappointing results from its phase 2 STAR 1 clinical trial for its adult epilepsy treatment: Link
On tempo with the broader growth trends in the major equity market indices, TD Ameritrade Holding Corp.'s (NASDAQ:AMTD) monthly survey of investor activity, the Investor Movement Index (IMX), reached a new high of 7.09 over the month of July: Link
Wall Street Journal
Reuters
Bloomberg
New York Post
ECONOMIC DATA
- US July NFIB small business optimism 105.2 vs 103.5 exp
- The Johnson Redbook Retail Sales Index for the latest week will be released at 8:55 a.m. ET.
- The Labor Department's JOLTS report for June is schedule for release at 10:00 a.m. ET.
- The Treasury is set to auction 4-week bills at 11:30 a.m. ET.
- The Treasury will auction 3-year notes at 1:00 p.m. ET.
ANALYST RATINGS
This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email [email protected].
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
